Armistice Capital »

Gossamer Bio shares owned by Armistice Capital

Quarter-by-quarter ownership of Gossamer Bio (GOSS) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Gossamer Bio

Tip: Access up to 7 years of quarterly data

All positions including Gossamer Bio held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gossamer Bio by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.1M 5.0M 0.83

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Gossamer Bio

NEA Management Company
Artal Group
Vanguard Group
EcoR1 Capital
Octagon Capital Advisors
Arch Venture Corp
Citadel Advisors
Samsara BioCapital
Palo Alto Investors
Madison Avenue Partners
Hillhouse Capital Advisors
Millennium Management
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Monashee Investment Management

View all funds holding Gossamer Bio